Development of a conditionally replicating vaccinia virus platform As an alternative to Modified Vaccinia Ankara for cancer immunotherapy and vaccine production
Development of a conditionally replicating vaccinia virus platform As an alternative to Modified Vaccinia Ankara for cancer immunotherapy and vaccine production
开发条件复制痘苗病毒平台作为改良痘苗安卡拉的替代品，用于癌症免疫治疗和疫苗生产
批准号：
474641
负责人：
Rezaei Reza
金额：
$10.93万
依托单位：
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2022
资助国家：
加拿大
项目状态：
未结题
起止时间：
2022-11-01 至 2025-11-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Supervisors: John Bell & Carolina Ilkow, uOttawa
The COVID-19 pandemic demonstrated the importance of flexible, readily available, and local vaccine platforms in the event of another potential viral infection. The development of improved vaccine platform
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金
